Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology; D002396:Catechols / Q000378:metabolism; D002849:Chromatography, Gas; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology*; D006900:Hydroxylation; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000382:microbiology; D008297:Male; D010648:Phenylacetates / Q000652:urine; D051381:Rats
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002396:Catechols; D006834:Hydrazines; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D001545:Benserazide